在患者和危险人群中应对亨廷顿病
Abigail L B Snow1,2, Abagail E Ciriegio1, Kelly H Watson2
1Department of Psychology and Human Development, Vanderbilt University, Nashville, TN, USA.
Journal of Huntington's disease
|August 16, 2024
概括
患有亨廷顿病 (HD) 的人和那些有风险的人会经历压力. 二次控制应对策略显著减少了这一群体的抑郁和焦虑症状.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 遗传学 是一个遗传学.
背景情况:
- 亨廷顿病 (HD) 对患者和风险人群造成重大压力.
- 有限的研究存在于应对机制及其与HD心理症状的联系.
研究的目的:
- 检查HD患者和风险人群使用的应对策略.
- 使用基于控制的模型,研究应对策略与抑郁/焦虑症状之间的关联.
主要方法:
- 49名 Huntington 病患者和76名风险人群完成了应对压力的反应问卷 - 亨廷顿病版本.
- 标准化措施评估了抑郁和焦虑症状.
- 患者的健康记录提供了疾病特征数据.
主要成果:
- 报告了对初级控制,二级控制和脱离应对策略的可比使用.
- 在这两组中,对二次控制的应对与抑郁和焦虑症状的减少有显著的关联.
结论:
- 二次控制应对似乎对HD患者和风险人群有益.
- 未来的研究应该探索纵向研究和干预措施,如认知重构和对HD家族的接受.
相关概念视频
Coping Strategies: Problem Focused
55
Coping strategies are methods people use to manage, tolerate, or reduce the effects of stressors. These strategies involve both behavioral and psychological actions to handle stressful situations. One common approach is problem-focused coping, which aims to change or eliminate the source of stress rather than merely addressing its consequences. This method involves taking direct action to resolve the issue causing stress.
For example, consider a student who struggles to understand their...
For example, consider a student who struggles to understand their...
55
Coping Strategies: Emotion Focused
64
Emotion-focused coping refers to a set of strategies aimed at managing the emotional impact of stressors, rather than directly addressing their causes. This approach involves altering one's emotional response to stressful situations to reduce their psychological effects. For example, individuals might talk with a friend or engage in activities like journaling to express their feelings. Such actions can help achieve emotional clarity or release, providing the psychological stability needed...
64
Parkinson's Disease: Treatment
240
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Stress Prevention and Stress Management Techniques VI
30
Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
30
Parkinson's Disease: Overview
501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501


